Jaktinib Hydrochloride Tablets ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 271 | 強直性脊椎炎 | 1 |
271. 強直性脊椎炎
臨床試験数 : 563 / 薬物数 : 372 - (DrugBank : 72) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 145
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04507659 (ClinicalTrials.gov) | December 2020 | 4/8/2020 | Jaktinib Hydrochloride Tablets In The Treatment of Active Ankylosing Spondylitis | A Multi-center, Randomized, Double-blind, Placebo, Parallel-controlled Phase ? Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Patients With Active Ankylosing Spondylitis | Ankylosing Spondylitis | Drug: Jaktinib Hydrochloride Tablets;Drug: Placebo | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | NULL | Not yet recruiting | 18 Years | 65 Years | All | 105 | Phase 2 | NULL |